Cheng Ying, Jilin Cancer Hospital director and AstraZeneca-funded scientist, dies suddenly
There has been no official statement about the doctor's death, and the cause of death is not known.
Cheng was director of the Jilin Cancer Hospital and according to their outpatient records, she last appeared at the specialist team clinic she led on the morning of July 2. Subsequently, her appointment schedule was removed from the hospital's outpatient information sheet, and news about her from the past year has been removed from the hospital's website.
10:51
New oral treatment for blood cancer offers 97% cure rate, Hong Kong researchers say
New oral treatment for blood cancer offers 97% cure rate, Hong Kong researchers say
The most recent publicly documented appearance by Cheng was on May 10 at the annual meeting of the small-cell carcinoma committee of the Chinese Anti-Cancer Association in Changchun.
Cheng served as chairwoman of the committee at the meeting, where she presented and released a report on research into small-cell carcinoma.
Cheng was a top-tier cancer expert in China. In July 1986, she graduated from Bethune Medical University, now called the School of Medicine, Jilin University.
She then held positions including director, deputy president, president and party secretary at Jilin Cancer Hospital.
In 2009, she received the Chinese medical profession's highest honour, the Chinese Physician Award, and in 2014, was named Outstanding Hospital President by the Chinese Hospital Association.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South China Morning Post
a day ago
- South China Morning Post
China girl with heart infection wakes up from coma when shown college acceptance letter
A student in central China who suffered from a heart infection and fell into a coma woke up when she was shown her college acceptance letter. On July 11, Jiang Chennan, 18, from Henan province sought medical help for fever and chest tightness, just after taking the 'gaokao', or national college entrance examination, in June, the mainland media outlet Jiupai News reported. Doctors diagnosed Jiang with fulminant myocarditis, the exact cause of which in her case remains unknown. The uncommon condition is characterised by a sudden and severe inflammation of the heart, which often leads to death. Key triggers include viral infections, emotional stress and a poor lifestyle. Jiang Chennan in her hospital bed. She slipped into a coma and was being kept alive artificially. Photo: handout After being transferred to another hospital, Jiang fell into a coma and was kept alive with artificial heart-lung support in the intensive care unit.
South China Morning Post
a day ago
- South China Morning Post
36.53% of Hong Kong students get university, diploma spots under allocation system
About 37 per cent of students who applied under Hong Kong's university programme allocation system have secured tertiary education places, representing a slight drop from the previous year, amid increased competition. The release of the allocation data on Tuesday came as the Chinese University of Hong Kong (CUHK) revealed it had secured the highest number of top scorers who sat their Diploma of Secondary Education (DSE) exams this year, with all of them opting to join its medicine programme. According to the figures, 36.53 per cent of applicants, or 15,808, were offered spots at local universities or on a subsidised diploma course under the Joint University Programmes Admissions System (Jupas). In comparison, 15,776, or 39.8 per cent, secured places last year. This year also saw the number of applicants increase by 9 per cent, going from 39,634 to 43,269, resulting in the proportion of successful candidates declining by 3.27 percentage points. Students are set to learn about their offers from 9am on Wednesday via the Jupas website or SMS.
South China Morning Post
2 days ago
- South China Morning Post
Alibaba, Beijing United Family Hospital partner to use AI in cancer diagnosis, treatment
The collaboration will leverage Damo Academy's medical artificial intelligence system, called 'One Sweep Multi-Check', as part of efforts to offer multi-disease AI screening services to the public, according to Monday's statement from Hangzhou -based Alibaba, owner of the South China Morning Post. 'We look forward to working with Damo Academy to drive the health management gateway for cancer and chronic diseases ever forward with cutting-edge AI screening technology,' BJU president Pan Zhongying said in the statement. She pointed out that the AI-based screening system would 'provide more efficient, reliable and people-centred healthcare'. The collaboration with BJU – a full-service, internationally accredited healthcare provider – showed how far Alibaba's research arm has bolstered the credentials of its AI-powered cancer detection tools. Damo Academy's AI screening system, which can identify a variety of diseases through a single flat computed tomography (CT) scan, provides a quick and low-cost solution to the growing problem of cancer diagnoses. According to 2024 estimates from the World Health Organization , global cancer diagnoses are expected to top 35 million by 2050. The facade of Beijing United Family Hospital in the Chaoyang district of China's capital. Photo: Handout The academy's strategic partnership with BJU would also be extended to detecting various chronic diseases, such as osteoporosis and severe fatty liver disease, to address the healthcare challenges of China's ageing population
